ROYAL BANK OF CANADA - ASSERTIO THERAPEUTICS INC ownership

ASSERTIO THERAPEUTICS INC's ticker is ASRT and the CUSIP is 04545L107. A total of 155 filers reported holding ASSERTIO THERAPEUTICS INC in Q3 2018. The put-call ratio across all filers is 0.37 and the average weighting 0.0%.

Quarter-by-quarter ownership
ROYAL BANK OF CANADA ownership history of ASSERTIO THERAPEUTICS INC
ValueSharesWeighting
Q1 2020$11,000
+175.0%
16,712
+403.4%
0.00%
Q4 2019$4,000
-42.9%
3,320
-42.5%
0.00%
Q3 2019$7,000
-99.0%
5,777
-97.2%
0.00%
Q2 2019$708,000
+70700.0%
205,129
+124220.6%
0.00%
Q1 2019$1,000
-93.8%
165
-93.9%
0.00%
Q3 2018$16,0002,6900.00%
Other shareholders
ASSERTIO THERAPEUTICS INC shareholders Q3 2018
NameSharesValueWeighting ↓
Senvest Management, LLC 5,006,637$29,439,0002.23%
ARMISTICE CAPITAL, LLC 3,000,000$17,640,0001.06%
DELTEC ASSET MANAGEMENT LLC 517,606$3,044,0000.58%
PERKINS CAPITAL MANAGEMENT INC 125,550$738,0000.44%
Matarin Capital Management, LLC 600,223$3,529,311,0000.23%
GLOBEFLEX CAPITAL L P 196,615$1,156,0000.23%
ALGERT GLOBAL LLC 139,129$818,0000.18%
TSP Capital Management Group, LLC 53,575$315,0000.16%
CORNERCAP INVESTMENT COUNSEL INC 157,235$925,0000.12%
Connor, Clark & Lunn Investment Management Ltd. 3,060,189$17,994,0000.10%
View complete list of ASSERTIO THERAPEUTICS INC shareholders